Sleep feels lighter? Recovery takes longer? Your body composition changes despite eating well and training consistently. If this sounds familiar, you're not imagining it.

Perimenopause is one of the biggest physiological transitions a woman experiences, yet many women are left wondering why the strategies that worked in their 20s and 30s suddenly stop delivering the same results.

While Hormone Replacement Therapy (HRT) remains one of the most evidence-based treatments for managing menopausal symptoms, interest is growing in peptides as an area of scientific research. Rather than replacing hormones, researchers are investigating whether certain peptides may support recovery, metabolism, skin health and healthy ageing.

In this guide, we'll explore what current research tells us and where the evidence is still evolving.

 

 

What Is Perimenopause?

Perimenopause is the transition leading up to menopause, typically beginning between the ages of 40 and 50, although it can start earlier.

During this time, oestrogen and progesterone levels fluctuate significantly rather than declining in a straight line. These hormonal changes can affect almost every system in the body.

Common symptoms include:

• Weight gain, particularly around the abdomen

• Poor sleep

• Fatigue

• Brain fog

• Mood changes

• Reduced muscle mass

• Slower recovery from exercise

• Joint discomfort

• Dry skin and reduced skin elasticity

• Reduced libido

Many women also notice they gain body fat more easily while finding it harder to maintain muscle despite eating well and exercising consistently.

 

Why Does Recovery Change During Perimenopause?

Oestrogen is far more than a reproductive hormone.

It plays important roles in:

• Muscle protein synthesis

• Collagen production

• Bone health

• Insulin sensitivity

• Sleep quality

• Inflammation regulation

As hormone levels fluctuate, many women experience:

• More muscle soreness after training

• Slower recovery

• Increased stiffness

• Reduced energy

• Lower exercise performance

This is why training, nutrition and recovery often need adjusting during perimenopause rather than simply training harder.

 

Where Do Peptides Fit In?

It is important to understand that peptides do not treat perimenopause.

Instead, researchers are exploring whether certain peptides may help support physiological systems that become affected during hormonal change.

Current areas of research include:

• Recovery

• Muscle preservation

• Connective tissue

• Skin health

• Metabolic health

• Cellular energy

The level of evidence varies considerably between peptides. Some have early human research, while others are still being investigated in laboratory and animal studies.

 

GHK-Cu 

GHK-Cu is one of the most researched peptides in the healthy ageing field.

Naturally found in the body, GHK-Cu levels decline as we age.

Researchers have investigated GHK-Cu for its potential role in:

• Supporting collagen production

• Improving skin elasticity

• Tissue repair

• Hair health

• Wound healing

As collagen production naturally declines during perimenopause, GHK-Cu has attracted increasing scientific interest.

 

NAD+ 

Although NAD+ is not a peptide, it is commonly discussed within longevity research.

NAD+ plays an essential role in cellular energy production and mitochondrial function.

Researchers continue investigating its potential role in supporting:

• Cellular energy

• Healthy ageing

• Cognitive function

• Mitochondrial health

Natural NAD+ levels decrease with age, making this an active area of research.

 

BPC-157 

BPC-157 has become one of the most widely researched peptides for connective tissue.

Current research has explored its potential role in supporting:

• Tendons

• Ligaments

• Soft tissue

• Gastrointestinal health

• Recovery processes

Many women report increased joint discomfort and slower recovery during perimenopause, making this an area of growing scientific interest.

It is important to note that much of the available evidence remains preclinical, and more human studies are needed.

 

CJC-1295 (No DAC) & Ipamorelin

Growth hormone naturally declines with age.

Researchers continue investigating growth hormone secretagogues such as CJC-1295 (No DAC) and Ipamorelin because they stimulate the body's own release of growth hormone rather than supplying it directly.

Areas currently being researched include:

• Lean muscle preservation

• Recovery

• Sleep quality

• Body composition

Although these physiological changes overlap with those experienced during perimenopause, these compounds are not treatments for menopause.

 

GLP-1 Medications

Perimenopause can make maintaining a healthy body weight increasingly challenging.

One area receiving significant attention in medical research is GLP-1 receptor agonists. Originally developed to help manage type 2 diabetes, these medications are now being extensively researched for their effects on appetite regulation, body weight and overall metabolic health.

Hormonal changes during perimenopause can contribute to:

• Increased appetite

• Reduced insulin sensitivity

• Greater fat storage, particularly around the abdomen

• Changes in energy expenditure

• Difficulty losing weight despite healthy eating and regular exercise

GLP-1 receptor agonists work by mimicking a naturally occurring hormone involved in regulating appetite and blood glucose.

Researchers are investigating their potential to:

• Help regulate appetite

• Increase feelings of fullness after meals

• Improve blood glucose control

• Support clinically significant weight loss in appropriate individuals

• Improve markers of metabolic health

Emerging research also suggests that improving metabolic health during perimenopause may have wider benefits, including supporting cardiovascular health and reducing the risk of obesity-related conditions.

While these findings are encouraging, it is important to understand that GLP-1 medications are not treatments for perimenopause itself. Instead, they may help address some of the metabolic changes that can occur during this stage of life when prescribed and monitored by an appropriate healthcare professional.

Research into GLP-1 therapies continues to evolve, and scientists are working to better understand how they may complement established strategies such as resistance training, adequate protein intake, quality sleep and, where appropriate, hormone replacement therapy (HRT).

 

Lifestyle Still Comes First

While peptide research is exciting, the strongest scientific evidence for supporting women through perimenopause still centres around lifestyle.

Focus on:

✔ Progressive resistance training

✔ Eating sufficient protein

✔ Prioritising sleep

✔ Managing stress

✔ Staying physically active

✔ Maintaining muscle mass

✔ Speaking to a qualified healthcare professional about HRT where appropriate

 

Final Thoughts

Perimenopause is a complex transition that affects far more than reproductive health. Hormonal changes can influence recovery, metabolism, skin, connective tissue and body composition, often leaving women feeling like their bodies have changed overnight.

Researchers continue exploring compounds such as GHK-Cu, BPC-157, CJC-1295 with Ipamorelin and NAD+ for their potential roles in healthy ageing and recovery. While early findings are encouraging, many peptides still require larger, high-quality human studies before firm conclusions can be made.

At Elevr, we believe education should come before hype. Understanding where the evidence is strong and where it is still developing, helps researchers make informed decisions and stay up to date with advances in peptide science.

All products supplied by Elevr are intended strictly for laboratory research purposes only. They are not medicines and are not intended for human consumption, diagnosis, treatment, cure or prevention of any disease or medical condition. All information provided within this article is for educational and scientific discussion only and should not be interpreted as medical advice.